MAPT and Alzheimer disease: GO enrichment analysis and KEGG pathway enrichment analysis suggested that UR alkaloids exerted the effect of treating AD directly act on multiple AD pathological processes such as Aβ overproduction, tau hyperphosphorylation, synaptic dysfunction, and neuronal loss.